Stryker (SYK) is a publicly traded Healthcare sector company. As of May 20, 2026, SYK trades at $319.69 with a market cap of $120.08B and a P/E ratio of 36.92. SYK moved +1.01% today. Year to date, SYK is -7.83%; over the trailing twelve months it is -17.47%. Its 52-week range spans $281.00 to $406.19. Analyst consensus is strong buy with an average price target of $391.67. Rallies surfaces SYK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Stryker Raises Quarterly Dividend to $0.88, 4.8% Year-Over-Year Increase: Stryker's board declared a $0.88 per share quarterly dividend payable July 31, 2026, to shareholders of record at June 30, 2026. The payout reflects a 4.8% year-over-year increase and is unchanged from the prior quarter.
| Metric | Value |
|---|---|
| Price | $319.69 |
| Market Cap | $120.08B |
| P/E Ratio | 36.92 |
| EPS | $8.73 |
| Dividend Yield | 0.88% |
| 52-Week High | $406.19 |
| 52-Week Low | $281.00 |
| Volume | 2.45M |
| Avg Volume | 0 |
| Revenue (TTM) | $25.27B |
| Net Income | $3.34B |
| Gross Margin | 63.84% |
23 analysts cover SYK: 0 strong buy, 18 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $391.67.